These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37545223)

  • 1. TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma.
    Hudock TR; Barker VR; Manley BJ; Chobrutskiy A; Chobrutskiy BI; Diaz MJ; Song JJ; Blanck G
    Cancer Biomark; 2023; 38(1):103-110. PubMed ID: 37545223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.
    Yeagley M; Chobrutskiy BI; Gozlan EC; Medikonda N; Patel DN; Falasiri S; Callahan BM; Huda T; Blanck G
    Pediatr Hematol Oncol; 2021 Apr; 38(3):251-264. PubMed ID: 33616477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR CDR3-antigen chemical complementarity associated with poor ovarian cancer outcomes: A vestigial immune response to early cancer antigens?
    Barker VR; Varkhedi M; Patel DN; Hsiang M; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Am J Reprod Immunol; 2023 Jan; 89(1):e13639. PubMed ID: 36317868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities.
    Charkowick SV; Huda TI; Patel DN; Yeagley M; Arturo JF; Cios KJ; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Biochem Genet; 2024 Feb; 62(1):530-546. PubMed ID: 37392243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma.
    Hudock TR; Song JJ; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Viral Immunol; 2024 Jun; 37(5):259-265. PubMed ID: 38848306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease-free survival.
    Song JJ; Chobrutskiy A; Chobrutskiy BI; Cios KJ; Huda TI; Eakins RA; Diaz MJ; Blanck G
    J Med Virol; 2023 Aug; 95(8):e29043. PubMed ID: 37621059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression.
    Arias MA; Cios KJ; Kacsoh DB; Montgomery BE; Song JJ; Patel AR; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical features of melanoma tumor resident TRG CDR3s associated with better survival probabilities.
    Agnila DRL; Huda TI; Eakins RA; Patel DN; Hsiang M; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Melanoma Res; 2023 Aug; 33(4):275-282. PubMed ID: 37222076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma.
    Song JJ; Chobrutskiy A; Chobrutskiy BI; Cios KJ; Huda TI; Eakins RA; Diaz MJ; Blanck G
    Viral Immunol; 2023 Dec; 36(10):669-677. PubMed ID: 38052065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep targeted sequencing reveals the diversity of TRB-CDR3 repertoire in patients with preeclampsia.
    Guo C; Cai R; Cao X; Yang Y; Wang Q; He R; An L; Peng Z; Chen Y; Ni S; Tan X; Han J; Liu X; Lin L; Yu S; Wang X; Wang C; Ma X
    Hum Immunol; 2019 Oct; 80(10):848-854. PubMed ID: 30965079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder cancer.
    Waweru JW; Mwangi KW; Barker VR; Gozlan EC; Yeagley M; Blanck G; Makokha FW
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4359-4366. PubMed ID: 36098856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Sequencing Reveals Immunological Characteristics of the TRB-/IgH-CDR3 Region of Umbilical Cord Blood.
    Guo C; Wang Q; Cao X; Yang Y; Liu X; An L; Cai R; Du M; Wang G; Qiu Y; Peng Z; Han J; Ni S; Tan X; Jin L; Yu S; Wang H; Wang C; Wang X; Ma X
    J Pediatr; 2016 Sep; 176():69-78.e1. PubMed ID: 27373756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling the pattern of human TRB/IGH-CDR3 repertoire in liver transplantation patients via high-throughput sequencing analysis.
    Han FF; Fan H; Ren LL; Wang HG; Wang C; Ma X; Liu LH; He Q; Guo CL
    Scand J Immunol; 2020 Aug; 92(2):e12912. PubMed ID: 32458431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCR CDR3-CMV Antigen Chemical Complementaries Are Associated With a Worse Outcome for Renal Cell Carcinoma.
    Alkassab L; Diaz MJ; Fetcher EA; Huda TI; Paul S; Kumar S; Chobrutskiy A; Chobrutskiy BI; Song JJ; Blanck G
    Anticancer Res; 2024 Apr; 44(4):1505-1511. PubMed ID: 38537966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome.
    Blanco G; López-Aventín D; Pujol RM; Gómez-Llonín A; Puiggros A; López-Sánchez M; Estrach T; García-Muret MP; López-Lerma I; Servitje O; Bellosillo B; Muro M; Espinet B; Rabionet R; Gallardo F
    J Clin Lab Anal; 2023 Dec; 37(23-24):e24982. PubMed ID: 38115685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity.
    Eakins RA; Chobrutskiy A; Teer JK; Patel DN; Hsiang M; Huda TI; Zaman S; Sexton WJ; Coppola D; Falasiri S; Blanck G; Chobrutskiy BI
    Mol Immunol; 2022 Oct; 150():58-66. PubMed ID: 35987136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression.
    Pakasticali N; Chobrutskiy A; Patel DN; Hsiang M; Zaman S; Cios KJ; Blanck G; Chobrutskiy BI
    Cancer Inform; 2023; 22():11769351231177269. PubMed ID: 37313373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen.
    Cheng P; Cios KJ; Varkhedi M; Barker VR; Yeagley M; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Oncoscience; 2023; 10():59-66. PubMed ID: 37953875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Complementarity of Blood-Sourced, Breast Cancer-Related TCR CDR3s and the CMV UL29 and IE1 Antigens is Associated with Worse Overall Survival.
    Neerumalla P; Jain R; Aboujaoude MT; Hudock TR; Song JJ; Cao BH; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Biochem Genet; 2024 Oct; ():. PubMed ID: 39356353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worse Wilms' Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs.
    Rigby KL; Diaz MJ; Gozlan EC; Kacsoh DB; Song JJ; Hudock TR; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Cancer Genomics Proteomics; 2024; 21(5):439-447. PubMed ID: 39191494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.